Suppr超能文献

阿昔洛韦诱导的神经毒性:阿昔洛韦过量时的浓度-副作用关系

Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.

作者信息

Haefeli W E, Schoenenberger R A, Weiss P, Ritz R F

机构信息

Department of Internal Medicine, University Hospital (Kantonsspital), Basel, Switzerland.

出版信息

Am J Med. 1993 Feb;94(2):212-5. doi: 10.1016/0002-9343(93)90186-s.

Abstract

PURPOSE

To investigate the concentration-side effect relationship in a patient with severe acyclovir-induced neurotoxicity and to summarize the information available in the literature about central nervous system side effects due to acyclovir.

METHODS

Repeated blood samples were drawn in a patient with severe acyclovir overdose who developed coma and nonoliguric renal failure. The acyclovir levels measured by radioimmunoassay were related to the level of consciousness.

RESULTS

We measured the highest acyclovir serum levels reported so far (229.9 mumol/L = 51.8 mg/L). Impairment of consciousness developed with a remarkable temporal delay of 24 to 48 hours after occurrence of peak serum concentrations and resolved with a comparable delay after reaching the therapeutic range (anticlockwise hysteresis). Six days after discontinuation of the drug, central nervous system symptoms had resolved, and, 4 days later, renal function returned to pretreatment values.

CONCLUSIONS

The observation that neurotoxicity developed with a delay of 24 to 48 hours after acyclovir peak serum concentrations could explain the wide range of acyclovir levels reported in similar cases. Single drug level measurements may therefore be of little diagnostic value. Since toxicity develops with a remarkable delay, early removal of the drug (by hemodialysis) could possibly prevent central nervous toxicity.

摘要

目的

研究一名严重阿昔洛韦诱导神经毒性患者的血药浓度-副作用关系,并总结文献中关于阿昔洛韦引起的中枢神经系统副作用的可用信息。

方法

对一名因阿昔洛韦严重过量导致昏迷和非少尿性肾衰竭的患者多次采集血样。通过放射免疫测定法测得的阿昔洛韦水平与意识水平相关。

结果

我们测得的阿昔洛韦血清水平是迄今为止报道的最高水平(229.9 μmol/L = 51.8 mg/L)。意识障碍在血清浓度峰值出现后24至48小时出现明显的时间延迟,并在达到治疗范围后以类似的延迟得到缓解(逆时针滞后)。停药6天后,中枢神经系统症状得到缓解,4天后,肾功能恢复到治疗前水平。

结论

阿昔洛韦血清浓度峰值后24至48小时出现神经毒性的观察结果可以解释类似病例中报道的阿昔洛韦水平范围广泛的现象。因此,单次血药浓度测量可能诊断价值不大。由于毒性出现有明显延迟,早期清除药物(通过血液透析)可能预防中枢神经毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验